NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

XTL Biopharmaceuticals Ltd. 

Kiryat Weizmann, Science Park, Bldg 3
P.O. Box 370
Rehovot    76100  Israel
Phone: 972-8-932-4444 Fax: 972-8-930-4445


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
XTL Biopharmaceuticals Ltd. (XTLB) Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel 4/16/2009 11:25:50 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) Announces Financial Results for the Year Ended December 31, 2008 4/7/2009 10:34:04 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) Extraordinary General Meetings Statement; Board and Management Changes 3/19/2009 10:54:27 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma 3/19/2009 10:48:46 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) Extraordinary General Meetings Postponed Until March 18, 2009 3/11/2009 10:48:44 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 2/12/2009 9:50:56 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter 2/6/2009 8:23:33 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) Announces Receipt of NASDAQ Notice of Delisting 1/28/2009 10:35:38 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) Provides Update on Potential Strategic Alternatives 1/28/2009 6:30:11 AM    More...
XTL Biopharmaceuticals Ltd. (XTLB) Implements Restructuring Plan; Terminating Employment of 75% of Workforce 12/9/2008 6:55:21 AM    More...
123456